Health Condition 1: B070- Plantar wart
Conditions
Interventions
Intervention1: Injection Acyclovir: Effect of Injection acyclovir and injection measles, mumps and rubella is compared in management of cutaneous warts. Injection Acyclovir in dose of 0.1ml (70mg/ml)
Sponsors
NIL
Eligibility
Inclusion criteria
Inclusion criteria: Patients of all genders aged greater than 18 years having clinically confirmed newly diagnosed cutaneous warts
Exclusion criteria
Exclusion criteria: 1. Participants who are pregnant 2. Any allergic reaction to MMR, acyclovir or their components 3. Patient on immunosuppressive medications, radioherapy 4. Patients having genital, mucosal and plane warts
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare the effect of intralesional MMR vaccine vs intralesional Acyclovir in treatment of cutaneous wartsTimepoint: Both the drugs to be given every 2 weeks for maximum 5 treatments and result is assessed at every follow-up visit at every 4 weeks till 3 months | — |
Secondary
| Measure | Time frame |
|---|---|
| To compare the complications after intralesional MME and intralesional acyclovir in treatment of cutaneous wartsTimepoint: Complications of both the groups is assessed at every 2 weeks;To compare recurrence of warts after intralesional MMR vaccine vs intralesional acyclovir in 3 months followup periodTimepoint: 3 months follow-up period | — |
Countries
India
Contacts
Public ContactParkriti Dumolia
Dr SN Medical College
Outcome results
None listed